MedTrace Logo

Assessing Mobile Apps for Adult ADHD

NCT06256003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-03-11

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effects of mobile app digital therapies on cognitive function and symptoms in adults diagnosed with ADHD.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DEVICE

UC-A

Mobile app digital therapy

DEVICE

UC-N

Mobile app digital therapy

Sponsors & Collaborators

Principal Investigators

  • Robert Bilder, Ph.D · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-03
Primary Completion
2024-11-23
Completion
2024-11-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06256003 on ClinicalTrials.gov